NAFDAC Places Mofus Nigeria Products on Watchlist Pending Regulatory Investigation
Ayodeji Ake The National Agency for Food and Drug Administration and Control (NAFDAC) has placed products marketed by Mofus Nigeria Ltd on its watchlist pending the outcome of an ongoing
The National Agency for Food and Drug Administration and Control (NAFDAC) has placed products from Mofus Nigeria Ltd on a watchlist while they investigate potential regulatory issues. The products, linked to companies including Mofus Nigeria Ltd, Ayrtons Saunders Ltd in the UK, and Pharmaserve (North West) Ltd, are under scrutiny for alleged non-compliance and possible misrepresentation, per NAFDAC's statement.
NAFDAC has initiated an active investigation under reference number NAFDAC/PMS/2026/0029. They have also put these products under continuous monitoring and alerted relevant parties, urging them to report any issues they encounter. The agency advises everyone to be wary when dealing with products from Mofus Nigeria Ltd and to buy medical items only from licensed suppliers, keeping records of distribution to trace any issues if they arise.
Healthcare facilities, distributors, pharmacists, and Patent and Proprietary Medicine Vendors are being asked to fully cooperate with the ongoing investigation. The public is also encouraged to report any concerns about substandard or falsified medicines to the nearest NAFDAC office. The watchlist remains active until the investigation concludes.
Written by urgent.news from This Day's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
